SolicitationPosted Jul 16, 2026·Responses due Jul 27, 2026

Building Exterior Repair Project � FDA Pacific Southwest Laboratory

FDA · FDA OFFICE OF ACQ GRANT SVCS

Stage
Open solicitation
NAICS
238320
Value
Not stated
Solicitation
75F40126R00047
Set-aside
Small Business Set Aside - Total
PSC
Z1JZ
Place
Irvine, CA, USA
Contact
Sheneil Green (Sheneil.Green@fda.hhs.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75F40126R00047 in this department, oldest first.

Early notice
None posted
Solicitation
  • Jun 16, 2026
    Solicitation
    Open
  • Jul 6, 2026
    Solicitation
    Open
  • Jul 16, 2026 · this notice
    Solicitation
  • Jul 21, 2026
    Solicitation
    Open
Award
Not yet. Too few past cases at this agency to estimate timing (6 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

Amendment 0001 is issued to exnted the due date and time while the Government finalizes its resposne to questions. ******************************************* The Mandatory Site Visit Attendee List is posted. Please refer to "75F40126R00047 Site Visit Attendee List 260711". ******************************************** The U.S. Food and Drug Administration (FDA), Office of Facilities Engineering and Mission Support Services (OFEMS), has a requirement for exterior and interior repair and preventative maintenance of the Pacific Southwest Laboratory located at 19701 Fairchild Road, Irvine, Califor… (show all)

nia 92612. The project consists primarily of: � Structural steel surface preparation and application of corrosion-resistant coating systems on exterior stairs, sunshades, roof access stairs, entrance canopies, and chemical storage shed structural components. � Interior and exterior non-structural concrete crack repairs, including associated surface restoration and replacement of damaged resilient flooring where required. � Associated mobilization, quality control testing, safety controls, closeout documentation, and warranty requirements. The facility will remain occupied and operational during construction. Contractors shall coordinate all work with FDA facility personnel and comply with applicable security, safety, and access requirements. The requirement is being solicited as a competitive 100 percent Small Business Set-Aside. TYPE OF CONTRACT: The Government intends to award a Firm-Fixed-Price construction contract. PERIOD OF PERFORMANCE: The Contractor shall achieve substantial completion within 180 calendar days after issuance of the Notice to Proceed (NTP). A one-year workmanship warranty shall be required following final acceptance. WAGE DETERMINATION: Construction Wage Determination CA20260024, Modification 03, dated May 18, 2026, applies to this requirement. BONDS: Performance and Payment Bonds will be required from the successful offeror within fifteen (15) calendar days after contract award. SITE VISIT: A mandatory site visit will be conducted: Date: July 1, 2026 Time: 8:30 AM Pacific Time Location: FDA Pacific Southwest Laboratory Irvine, CA 92612 Registration for the site visit is required no later than June 26, 2026. Attendance is mandatory. Proposals from firms that do not attend the site visit will be considered non-responsive. Interested offerors are advised to thoroughly review the complete solicitation package, including the SF 1442, Performance Work Statement (PWS), drawings, specifications, wage determination, pricing schedule, security requirements, and all attachments and amendments. The Government will not be responsible for an offeror's failure to examine all solicitation documents and site conditions affecting contract performance. Offerors are responsible for ensuring their proposals fully comply with all solicitation requirements, instructions, terms, conditions, specifications, and attachments.

Who won similar work

24 award notices on SAM.gov in the last 24 months. Matched by: Same agency (FDA), any industry: a loose match.

Loose match: same agency, any industry. Read the titles before treating these as competitors.

Single-winner award sizes (24): middle half $402K to $19.1M, median $2.6M; range $82K to $120.8M.

WinnerAwardsValueLast
Please_See_Spreadsheet Silver Spring MD 20993 USA3$153.2MOct 8, 2026
DCT, INCORPORATED1$52.8MSep 15, 2026
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC1$50.0MSep 16, 2025
NATI-NVE Support Services, LLC1$49.0MMay 21, 2026
HARVARD PILGRIM HEALTH CARE INC1$31.7MMar 30, 2026
TOXICOLOGIC PATHOLOGY ASSOCIATES INC1$26.1MSep 15, 2025
IHRC, INCORPORATED1$14.5MSep 16, 2026
VITALANT Scottsdale AZ 85258 USA1$10.0MSep 8, 2025
WE PHARMA, INC.1$4.0MSep 11, 2026
THE BIONETICS CORP1$2.8MJul 21, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Food & Drug Administration (FDA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Food & Drug Administration (FDA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 129 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.